van Puijenbroek E - Search Results

1

Intensive monitoring of pregabalin: results from an observational, Web-based, prospective cohort study in the Netherlands using patients as a source of information.

Härmark L, van Puijenbroek E, Straus S, van Grootheest K. Härmark L, et al. Among authors: van grootheest k, van puijenbroek e. Drug Saf. 2011 Mar 1;34(3):221-31. doi: 10.2165/11585030-000000000-00000. Drug Saf. 2011. PMID: 21332246

2

Association between terbinafine and arthralgia, fever and urticaria: symptoms or syndrome?

van Puijenbroek EP, Egberts AC, Meyboom RH, Leufkens HG. van Puijenbroek EP, et al. Pharmacoepidemiol Drug Saf. 2001 Mar-Apr;10(2):135-42. doi: 10.1002/pds.581. Pharmacoepidemiol Drug Saf. 2001. PMID: 11499852

3

Determinants of signal selection in a spontaneous reporting system for adverse drug reactions.

van Puijenbroek EP, van Grootheest K, Diemont WL, Leufkens HG, Egberts AC. van Puijenbroek EP, et al. Among authors: van grootheest k. Br J Clin Pharmacol. 2001 Nov;52(5):579-86. doi: 10.1046/j.0306-5251.2001.01501.x. Br J Clin Pharmacol. 2001. PMID: 11736867 Free PMC article.

4

A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.

van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC. van Puijenbroek EP, et al. Pharmacoepidemiol Drug Saf. 2002 Jan-Feb;11(1):3-10. doi: 10.1002/pds.668. Pharmacoepidemiol Drug Saf. 2002. PMID: 11998548

5

Contribution of pharmacists to the reporting of adverse drug reactions.

van Grootheest AC, van Puijenbroek EP, de Jong-van den Berg LT. van Grootheest AC, et al. Among authors: van puijenbroek ep. Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):205-10. doi: 10.1002/pds.702. Pharmacoepidemiol Drug Saf. 2002. PMID: 12051119

6

Use of measures of disproportionality in pharmacovigilance: three Dutch examples.

Egberts AC, Meyboom RH, van Puijenbroek EP. Egberts AC, et al. Drug Saf. 2002;25(6):453-8. doi: 10.2165/00002018-200225060-00010. Drug Saf. 2002. PMID: 12071783

7

Application of quantitative signal detection in the Dutch spontaneous reporting system for adverse drug reactions.

van Puijenbroek E, Diemont W, van Grootheest K. van Puijenbroek E, et al. Among authors: van grootheest k. Drug Saf. 2003;26(5):293-301. doi: 10.2165/00002018-200326050-00001. Drug Saf. 2003. PMID: 12650632

8

Bladder dysfunction during the use of tramadol.

Meyboom RH, Brodie-Meijer CC, Diemont WL, van Puijenbroek EP. Meyboom RH, et al. Among authors: van puijenbroek ep. Pharmacoepidemiol Drug Saf. 1999 Apr;8 Suppl 1:S63-4. doi: 10.1002/(sici)1099-1557(199904)8:1+3.3.co;2-d. Pharmacoepidemiol Drug Saf. 1999. PMID: 15073888

9

Do pharmacists' reports of adverse drug reactions reflect patients' concerns?

van Grootheest K, van Puijenbroek EP, de Jong-van den Berg LT. van Grootheest K, et al. Pharm World Sci. 2004 Jun;26(3):155-9. doi: 10.1023/b:phar.0000026802.81401.bb. Pharm World Sci. 2004. PMID: 15230363

10

[Side effects of tramadol: 12 years of experience in the Netherlands].

Kabel JS, van Puijenbroek EP. Kabel JS, et al. Among authors: van puijenbroek ep. Ned Tijdschr Geneeskd. 2005 Apr 2;149(14):754-7. Ned Tijdschr Geneeskd. 2005. PMID: 15835626 Review. Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters